Consequences of unsafe prescribing of transdermal fentanyl.
作者信息
Lucyk Scott, Nelson Lewis
机构信息
Emergency Medicine, University of Calgary, and Poison and Drug Information Service (Lucyk), Alberta Health Services, Calgary, Alta.; Emergency Medicine and Medical Toxicology (Nelson), New York University School of Medicine, New York, NY.
出版信息
CMAJ. 2016 Jun 14;188(9):638-639. doi: 10.1503/cmaj.160291. Epub 2016 Apr 4.
Abstract
摘要
相似文献
1
Consequences of unsafe prescribing of transdermal fentanyl.经皮芬太尼不安全处方的后果。
CMAJ. 2016 Jun 14;188(9):638-639. doi: 10.1503/cmaj.160291. Epub 2016 Apr 4.
2
Transdermal fentanyl: informed prescribing is essential.透皮芬太尼：明智的处方开具至关重要。
Eur J Pain. 2003;7(5):481-3. doi: 10.1016/S1090-3801(02)00148-9.
3
Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.在癌症疼痛患者中未预先进行阿片类药物稳定化处理就使用透皮芬太尼。
Curr Med Res Opin. 2004 Mar;20(3):259-67. doi: 10.1185/030079903125003026.
4
A pitfall to avoid when starting a patient on transdermal fentanyl.开始给患者使用透皮芬太尼时要避免的一个陷阱。
Aust Fam Physician. 2000 Dec;29(12):1173-5.
5
Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.预测癌症疼痛患者从口服吗啡或羟考酮转换为使用芬太尼透皮贴剂时需要高剂量的因素。
Clin J Pain. 2011 Oct;27(8):664-7. doi: 10.1097/AJP.0b013e3182168fed.
6
The role of transdermal fentanyl patches in the effective management of cancer pain.透皮芬太尼贴剂在癌症疼痛有效管理中的作用。
Int J Palliat Nurs. 2009 Jul;15(7):354-9. doi: 10.12968/ijpn.2009.15.7.43426.
7
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.透皮芬太尼：其药理特性及在慢性癌痛控制中的治疗效果的最新综述
Drugs. 2001;61(15):2289-307. doi: 10.2165/00003495-200161150-00014.
8
An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.一种用于癌症相关疼痛的透皮芬太尼给药的替代算法。
Oncology (Williston Park). 2000 May;14(5):695-705; discussion 705, 709-17.
9
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.透皮芬太尼治疗慢性疼痛的获益-风险评估。
Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004.
10
Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.姑息治疗患者经皮和口服阿片类药物的临床经验——一项回顾性研究。
Jpn J Clin Oncol. 2007 Apr;37(4):302-9. doi: 10.1093/jjco/hym017. Epub 2007 May 22.
引用本文的文献
1
National opioid crisis.全国性阿片类药物危机。
CMAJ. 2016 Oct 18;188(15):1107. doi: 10.1503/cmaj.1150125.
本文引用的文献
1
Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.根据既往阿片类药物暴露情况，新开具芬太尼透皮贴剂患者起始使用芬太尼的安全性。
CMAJ. 2016 Jun 14;188(9):648-653. doi: 10.1503/cmaj.150961. Epub 2016 Apr 4.
2
Methadone-related deaths. A ten year overview.美沙酮相关死亡。十年综述。
Forensic Sci Int. 2015 Dec;257:172-176. doi: 10.1016/j.forsciint.2015.08.017. Epub 2015 Aug 31.
3
Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.处方类阿片类药物作用持续时间与接受阿片类药物治疗患者发生意外药物过量的风险。
JAMA Intern Med. 2015 Apr;175(4):608-15. doi: 10.1001/jamainternmed.2014.8071.
4
Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.阿片类药物处方：慢性疼痛治疗指南的系统评价和批判性评估。
Ann Intern Med. 2014 Jan 7;160(1):38-47. doi: 10.7326/0003-4819-160-1-201401070-00732.
5
Complications of oral exposure to fentanyl transdermal delivery system patches.口腔接触芬太尼透皮贴剂的并发症。
J Med Toxicol. 2010 Dec;6(4):443-7. doi: 10.1007/s13181-010-0092-8.
6
Transdermal fentanyl: pharmacology and toxicology.经皮芬太尼：药理学和毒理学。
J Med Toxicol. 2009 Dec;5(4):230-41. doi: 10.1007/BF03178274.
Zotero 插件